RichardDWortzelMD

PubMed

• Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cel...
  Van Waes, C., Monach, P. A., Urban, J. L., Wortzel, R. D., Schreiber, H.> ;Tissue Antigens. 1996 May
• Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.
  Wortzel, R. D., Urban, J. L., Schreiber, H.> ;Proc Natl Acad Sci U S A. 1984 Apr
• Multiple tumour-specific antigens expressed on a single tumour cell.
  Wortzel, R. D., Philipps, C., Schreiber, H.> ;Nature. 1983 Jul 14
• Dissection of a unique tumor-specific transplantation antigen into multiple unique independent epitopes using syngeneic T-cell lines.
  Wortzel, R. D., Philipps, C., Urban, J. L., Schreiber, H.> ;Haematol Blood Transfus. 1983
• Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
  Wortzel, R. D., Urban, J. L., Philipps, C., Fitch, F. W., Schreiber, H.> ;J Immunol. 1983 May
• Dissection of tumour-specific antigenicity.
  Wortzel, R. D., Stauss, H. J., Van Waes, C., Schreiber, H.> ;Cancer Surv. 1985 Jan 01
• The complexity of unique tumor-specific antigens.
  Wortzel, R. D., Stauss, H. J., Van Waes, C., Schreiber, H.> ;Symp Fundam Cancer Res. 1986 Jan 01
• A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structure.
  Philipps, C., Stauss, H. J., Wortzel, R. D., Schreiber, H.> ;J Immunogenet. 1986 Apr 01
• Join now to see all